JP2023549533A5 - - Google Patents
Info
- Publication number
- JP2023549533A5 JP2023549533A5 JP2023528761A JP2023528761A JP2023549533A5 JP 2023549533 A5 JP2023549533 A5 JP 2023549533A5 JP 2023528761 A JP2023528761 A JP 2023528761A JP 2023528761 A JP2023528761 A JP 2023528761A JP 2023549533 A5 JP2023549533 A5 JP 2023549533A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- solvate
- hydrogen
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113691P | 2020-11-13 | 2020-11-13 | |
| US63/113,691 | 2020-11-13 | ||
| US202163215818P | 2021-06-28 | 2021-06-28 | |
| US63/215,818 | 2021-06-28 | ||
| PCT/US2021/072405 WO2022104383A1 (en) | 2020-11-13 | 2021-11-15 | Pharmacological agents for treating conditions of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549533A JP2023549533A (ja) | 2023-11-27 |
| JP2023549533A5 true JP2023549533A5 (https=) | 2024-11-25 |
Family
ID=81601792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528761A Pending JP2023549533A (ja) | 2020-11-13 | 2021-11-15 | 眼の状態を処置するための薬理剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240000812A1 (https=) |
| EP (1) | EP4243798A4 (https=) |
| JP (1) | JP2023549533A (https=) |
| CA (1) | CA3202073A1 (https=) |
| MX (1) | MX2023005675A (https=) |
| WO (1) | WO2022104383A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11872236B2 (en) | 2018-04-05 | 2024-01-16 | Calasia Pharmaceuticals, Inc. | Pharmacological agents for treating ocular diseases |
| CN116963727A (zh) * | 2020-11-13 | 2023-10-27 | 普莱克斯医药公司 | 用于治疗眼部病症的药剂 |
| WO2025090994A1 (en) * | 2023-10-26 | 2025-05-01 | Plex Pharmaceuticals, Inc. | Compositions for treating cataracts and/or presbyopia eye diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2329161T3 (es) * | 2006-12-18 | 2009-11-23 | Jorge Luis Benozzi | Composiciones oftalmicas de estimulantes parasimpaticos y antiinflamatorios para su uso en el tratamiento de la presbicia. |
| RU2747536C2 (ru) * | 2011-10-24 | 2021-05-06 | Сом Инновэйшн Биотек, С.Л. | Новая терапия транстиретин-ассоциированного амилоидоза |
| CA2860022A1 (fr) * | 2011-12-30 | 2013-07-04 | Universite D'auvergne Clermont I | Composes anti-douleur |
| WO2014164667A1 (en) * | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
| US20160317474A1 (en) * | 2013-12-18 | 2016-11-03 | Emory University | Managing Visual Dysfunction or Loss of Vision for Diabetic Subjects |
| US11872236B2 (en) * | 2018-04-05 | 2024-01-16 | Calasia Pharmaceuticals, Inc. | Pharmacological agents for treating ocular diseases |
| EP3683618A1 (en) * | 2019-01-21 | 2020-07-22 | Essilor International (Compagnie Generale D'optique) | System and method for demonstrating an optical disorder |
| CN116963727A (zh) * | 2020-11-13 | 2023-10-27 | 普莱克斯医药公司 | 用于治疗眼部病症的药剂 |
| US20240269066A1 (en) * | 2021-06-08 | 2024-08-15 | Precvision Biotechnologies Ltd. | Use of cyp450 inhibitor in inhibiting or killing mites and treating xerophthalmia |
-
2021
- 2021-11-15 EP EP21893092.3A patent/EP4243798A4/en active Pending
- 2021-11-15 MX MX2023005675A patent/MX2023005675A/es unknown
- 2021-11-15 CA CA3202073A patent/CA3202073A1/en active Pending
- 2021-11-15 US US18/037,021 patent/US20240000812A1/en active Pending
- 2021-11-15 WO PCT/US2021/072405 patent/WO2022104383A1/en not_active Ceased
- 2021-11-15 JP JP2023528761A patent/JP2023549533A/ja active Pending